Literature DB >> 10571293

Evaluation and transplantation of corneas from pseudophakic donor eyes.

E A Mindrup1, P A Dubbel, D J Doughman.   

Abstract

PURPOSE: To evaluate the quality of corneal donor tissue from pseudophakic eyes for transplantation.
METHODS: Only capsular-supported posterior chamber pseudophakia was studied. Forty-five pairs of donor eyes were assessed and evaluated by standard Minnesota Lions Eye Bank (MLEB) protocol. Thirty-three pairs were unilaterally pseudophakic with the unoperated phakic eye used as a control eye. Twelve donors were bilaterally pseudophakic. All corneas were rated for corneal clarity, epithelial defects, stromal edema, Descemet's membrane folding, endothelial cell density (ECD), and cell damage by slit-lamp examination and specular microscopy. If the corneas were not transplanted, the endothelium was vital stained with trypan blue and counterstained with alizarin red S for quantitation, localization, and visualization of cell morphology and damage.
RESULTS: Sixty-eight of the 90 corneas in this study did not meet transplantation criteria. A significant difference in ECD (>22%) and in overall corneal rating was found in seven (21%) of 33 pairs of unilateral pseudophakic donors. Fourteen corneal transplants were performed using corneas from the donors in this study. Nine corneas from pseudophakic donor eyes were transplanted, resulting in one primary graft failure reported.
CONCLUSION: Corneas from pseudophakic donor eyes may need more extensive evaluation for endothelial viability than is currently required by eye bank standards.

Entities:  

Mesh:

Year:  1999        PMID: 10571293     DOI: 10.1097/00003226-199911000-00004

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  1 in total

1.  Utilization rate and usage patterns of phakic and pseudophakic donor corneas recovered by the Singapore Eye Bank.

Authors:  Sai Kyauk; Howard Y Cajucom-Uy; Hla Myint Htoon; Z Zaw Htoi Aung; Jodhbir S Mehta; Arundhati Anshu
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.